…
Simulations Plus (SLP) delivered earnings and revenue surprises of +29.63% and +13.51%, respectively, for the quarter ended February 2026. Do…
Simulations Plus shares soar 9% after topping Q2 estimates…
NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
NEW YORK, Jan. 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
…
…
…
…
Simulations Plus (SLP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings…
…
…
Simulations Plus (SLP) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
The consensus price target hints at a 33.6% upside potential for Simulations Plus (SLP). While empirical research shows that this…
NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
Simulations Plus posted weak Q3 2025 results, including a $77.2M impairment and cut guidance, sending shares down 25.8% to $12.97…
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
NEW YORK, July 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
…
…
Simulations Plus (SLP) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Simulations Plus lowers FY25 revenue forecast and restructures operations as biotech headwinds hit services demand.…
Der Sektor "Healthcare" liegt aktuell im Mittelfeld aller Sektoren. In der letzten Woche gab es eine bahnbrechende Mitteilung durch die…
…
…
Simulations Plus fiscal Q2 2025 performance gains from its strong software solutions and services portfolio amid limited customer funding.…
Simulations Plus (SLP) delivered earnings and revenue surprises of 24% and 3.11%, respectively, for the quarter ended February 2025. Do…
…
…
Simulations Plus (SLP) delivered earnings and revenue surprises of -5.56% and 1.25%, respectively, for the quarter ended November 2024. Do…
…
Simulations Plus (SLP) enhances its business structure after recent acquisitions, and appoints new leaders for its redesigned business units…
Simulations Plus (SLP) announces a collaboration with ICCS on a research initiative to advance animal-free safety assessment of new chemicals…
Simulations Plus (SLP) fiscal third-quarter revenues are driven by strength in Software and Services units.…
…
…
After-hours movers: Tesla, First Foundation, Simulations Plus, and Rivian…
Simulation Plus (SLP) acquires Pro-ficiency from QHP Capital for $100 million in an all-cash transaction.…
Simulations Plus (SLP) unveils GastroPlus X, which significantly reduces time spent on model setup, data management, and reformatting results.…
For the seventh consecutive year, the FDA has renewed Simulations Plus (SLP) license to the DILIsym software system for facilitating…
…
…
Simulations Plus (SLP) second-quarter fiscal 2024 top line is driven by higher revenues in the Software and Services business segments.…
Simulations Plus (SLP) delivered earnings and revenue surprises of 11.11% and 7.24%, respectively, for the quarter ended February 2024. Do…
…
Simulations Plus (SLP) fiscal second-quarter performance is likely to have benefited from momentum across Software and Services business segments.…